Fort Sheridan Advisors LLC grew its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 3.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 12,584 shares of the healthcare product maker’s stock after purchasing an additional 402 shares during the quarter. Fort Sheridan Advisors […]
Creative Planning trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 6.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 751,772 shares of the healthcare product maker’s stock after selling 54,250 shares during the quarter. Creative Planning’s holdings in Abbott Laboratories […]
Mairs & Power Inc. trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 1.0% in the fourth quarter, Holdings Channel reports. The firm owned 1,285,461 shares of the healthcare product maker’s stock after selling 13,538 shares during the quarter. Abbott Laboratories accounts for 1.5% of Mairs & Power Inc.’s holdings, making the stock […]
Bellevue Group AG lessened its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,535,656 shares of the healthcare product maker’s stock after selling 25,312 shares during the quarter. Abbott Laboratories accounts […]
Bellevue Group AG lessened its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,535,656 shares of the healthcare product maker’s stock after selling 25,312 shares during the quarter. Abbott Laboratories accounts […]